Our Call-for-Abstracts for the 18th PACTRIMS is open.
SUBMIT HERE
(Please read conditions for submission.)
GUIDELINES FOR 2026:
Deadline
• Abstracts must be submitted by Monday, 3 August 2026, 23:59 hours (Singapore Standard Time, +8.00UTC). Strictly no extension will be granted.
Topics for your submissions:
- Epidemiology, Genetics, and Epigenetics
- Basic Science
- Neuropathology
- Neuroimaging and Neurophysiology
- Patient Reported Outcomes and Programs that Support Quality of Life
- Disease Modifying Therapies
- Infection as Differential Diagnosis and Treatment-related Diseases
- Symptom Management and Rehabilitation
- Advances in Technology in Diagnosis and Care
Submission Areas Include:
- Research Reports
These reports present completed original research on pharmacologic agents, therapeutic issues, and innovative services or outcomes of services provided to the patients with MS or related diseases.
- Research-in-Progress
These posters represent currently ongoing, uncompleted studies. The author may discuss preliminary results of the studies, provided the research methods have been validated. Topics may include clinical drug studies, therapeutics issues, innovative services, and outcomes.
- Case Studies
These posters present a description of the evidence-based management and treatment of a patient from the author’s clinical practice with an uncommon presentation and/or clinically challenging scenario, emphasizing steps taken to maximize the likelihood of an optimal outcome.
- Repeat Presentations
These posters represent findings that have been presented at other meetings but contain information of interest to clinicians who care for patients with MS or related diseases. These completed studies need to be original research on pharmacologic issues, therapeutic considerations, innovative services, or outcomes related to MS and related diseases.